Overview

Assessing a Dose-Response Relationship of Hydralazine and Its Effects on DNA Methyltransferase 1 in Polycystic Kidney Disease Patients

Status:
Completed

Trial end date:
2020-01-30

Target enrollment:

Participant gender:

Summary

The purpose of this study is to find a protein (ex. Polycystin 1 or mucin and cadherin like protein) in the urine that is changed after treatment of hydralazine.

Phase:

Early Phase 1

Details

Lead Sponsor:

University of Kansas Medical Center

Treatments:

Hydralazine